Literature DB >> 7999366

Role of FGFs in skeletal muscle and limb development.

B B Olwin1, K Arthur, K Hannon, P Hein, A McFall, B Riley, G Szebenyi, Z Zhou, M E Zuber, A C Rapraeger.   

Abstract

Fibroblast growth factors (FGFs) are a family of nine proteins that bind to three distinct types of cell surface molecules: (i) FGF receptor tyrosine kinases (FGFR-1 through FGFR-4); (ii) a cysteine-rich FGF receptor (CFR); and (iii) heparan sulfate proteoglycans (HSPGs). Signaling by FGFs requires participation of at least two of these receptors: the FGFRs and HSPGs form a signaling complex. The length and sulfation pattern of the heparan sulfate chain determines both the activity of the signaling complex and, in part, the ligand specificity for FGFR-1. Thus, the heparan sulfate proteoglycans are likely to play an essential role in signaling. We have recently identified a role for FGF in limb bud development in vivo. In the chick limb bud, ectopic expression of the 18 kDa form of FGF-2 or FGF-2 fused to an artificial signal peptide at its amino terminus causes skeletal duplications. These data, and the observations that FGF-2 is localized to the subjacent mesoderm and the apical ectodermal ridge in the early developing limb, suggest that FGF-2 plays an important role in limb outgrowth. We propose that FGF-2 is an apical ectodermal ridge-derived factor that participates in limb outgrowth and patterning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999366     DOI: 10.1002/mrd.1080390114

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  16 in total

1.  FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.

Authors:  Boguslaw A Kwiatkowski; Irina Kirillova; Robert E Richard; David Israeli; Zipora Yablonka-Reuveni
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 2.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

3.  Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing.

Authors:  A Bousvaros; D Zurakowski; S J Fishman; K Keough; T Law; C Sun; A M Leichtner
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Organization and reorganization of neuromuscular junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth factor-5.

Authors:  L M Moscoso; H Cremer; J R Sanes
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

5.  Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

Authors:  G J Jenniskens; A Oosterhof; R Brandwijk; J H Veerkamp; T H van Kuppevelt
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 6.  Current status and future prospect of FSHD region gene 1.

Authors:  Arman Kunwar Hansda; Ankit Tiwari; Manjusha Dixit
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

Review 7.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

8.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice.

Authors:  J D Coffin; R Z Florkiewicz; J Neumann; T Mort-Hopkins; G W Dorn; P Lightfoot; R German; P N Howles; A Kier; B A O'Toole
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

9.  Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis.

Authors:  Michael Phelps; Pascal Stuelsatz; Zipora Yablonka-Reuveni
Journal:  FEBS J       Date:  2016-04-13       Impact factor: 5.542

Review 10.  In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease.

Authors:  Alastair Khodabukus; Neel Prabhu; Jason Wang; Nenad Bursac
Journal:  Adv Healthc Mater       Date:  2018-04-25       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.